Pro-Dex beats Q1 revenue estimates

Pro-Dex

30/10/2025 20:07

Overview

Pro-Dex fiscal Q1 revenue grows 24% yr/yr, beating analyst expectations

Net income for fiscal Q1 more than doubles, aided by investment gains

Gross margin declines due to higher costs, including tariffs

Outlook

Company did not provide specific financial guidance in press release

Result Drivers

NEXT-GEN HANDPIECE - Revenue increase driven by resumption of next-gen handpiece shipments to largest customer

HIGHER COSTS - Gross margin decline attributed to higher costs, including tariffs, not fully passed to customers

INCREASED EXPENSES - Operating expenses rose due to higher personnel costs in HR, IT, and facilities

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$18.53 mln
$15.30 mln (1 Analyst)
Q1 EPS
$1.40
Q1 Net Income
$4.68 mln
Q1 Gross Profit
$5.36 mln
Q1 Operating Expenses
$2.25 mln


Analyst Coverage

The one available analyst rating on the shares is "buy"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

Wall Street's median 12-month price target for Pro-Dex Inc is $56.00, about 45.2% above its October 29 closing price of $30.71

Press Release: ID:nACSn6Xjla

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)